Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9538229rdf:typepubmed:Citationlld:pubmed
pubmed-article:9538229lifeskim:mentionsumls-concept:C0085536lld:lifeskim
pubmed-article:9538229lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:9538229lifeskim:mentionsumls-concept:C0678723lld:lifeskim
pubmed-article:9538229lifeskim:mentionsumls-concept:C0253470lld:lifeskim
pubmed-article:9538229lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:9538229lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:9538229lifeskim:mentionsumls-concept:C1719914lld:lifeskim
pubmed-article:9538229lifeskim:mentionsumls-concept:C2828406lld:lifeskim
pubmed-article:9538229lifeskim:mentionsumls-concept:C0458003lld:lifeskim
pubmed-article:9538229pubmed:issue3lld:pubmed
pubmed-article:9538229pubmed:dateCreated1998-5-26lld:pubmed
pubmed-article:9538229pubmed:abstractTextProtein tyrosine phosphatase zeta (PTPzeta/RPTPbeta) is a receptor-like protein tyrosine phosphatase specifically expressed in the brain. Alternative splicing produces three isoforms of this molecule: PTPzeta-A, the full-length form of PTPzeta; PTPzeta-B, the short form of PTPzeta; and PTPzeta-S, an extracellular variant. Here, we identified all these isoforms, including PTPzeta-B, as chondroitin sulfate proteoglycans, and characterized their carbohydrate modification and expression profiles in the rat brain. The level of PTPzeta-A expression was maintained during the prenatal period and decreased rapidly after birth. PTPzeta-S was expressed in a similar manner, although the postnatal decrease was gradual. In contrast, relatively constant amounts of PTPzeta-B were observed from embryonic day 13 (E13) through adulthood. PTPzeta-A and -S were constantly expressed only as proteoglycans during development, but a substantial amount of PTPzeta-B was detected in a non-proteoglycan form at E13-15. Moreover, PTPzeta-B did not contain LeX, HNK-1 carbohydrate, or keratan sulfate, although PTPzeta-A and -S were generally modified with these carbohydrates. L cells transfected with PTPzeta-A and -B cDNAs expressed these proteins as enzymatically active chondroitin sulfate proteoglycans. The PTPzeta-A and -B in L cells showed essentially similar localizations in cell cortical structures on immunofluorescence microscopy, although immature or processed forms of PTPzeta-A were accumulated additively in intracellular patchy structures. These results show that the three isoforms of PTPzeta are differentially regulated during development, and that the extracellular deleted region in PTPzeta-B is important for determination of carbohydrate modification.lld:pubmed
pubmed-article:9538229pubmed:languageenglld:pubmed
pubmed-article:9538229pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:citationSubsetIMlld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9538229pubmed:statusMEDLINElld:pubmed
pubmed-article:9538229pubmed:monthMarlld:pubmed
pubmed-article:9538229pubmed:issn0021-924Xlld:pubmed
pubmed-article:9538229pubmed:authorpubmed-author:MaedaNNlld:pubmed
pubmed-article:9538229pubmed:authorpubmed-author:NodaMMlld:pubmed
pubmed-article:9538229pubmed:authorpubmed-author:NishiwakiTTlld:pubmed
pubmed-article:9538229pubmed:issnTypePrintlld:pubmed
pubmed-article:9538229pubmed:volume123lld:pubmed
pubmed-article:9538229pubmed:ownerNLMlld:pubmed
pubmed-article:9538229pubmed:authorsCompleteYlld:pubmed
pubmed-article:9538229pubmed:pagination458-67lld:pubmed
pubmed-article:9538229pubmed:dateRevised2007-12-19lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:meshHeadingpubmed-meshheading:9538229-...lld:pubmed
pubmed-article:9538229pubmed:year1998lld:pubmed
pubmed-article:9538229pubmed:articleTitleCharacterization and developmental regulation of proteoglycan-type protein tyrosine phosphatase zeta/RPTPbeta isoforms.lld:pubmed
pubmed-article:9538229pubmed:affiliationDivision of Molecular Neurobiology, National Institute for Basic Biology, 38 Nishigonaka, Myodaiji-cho, Okazaki 444-8585, Japan.lld:pubmed
pubmed-article:9538229pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9538229pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9538229lld:pubmed